InvestWiser

Induct AS

INDCTOslo BørsHealthcareMarket value 21 m NOK
0.41NOK +2.2%
last day · Price as of 19 November 2026

The answer first

Does Induct beat the market?

No, Induct has not beaten the market over the last year.

Induct−88.8%Oslo Børs (OSEBX)+30.6%
  • The ranking · Quality, value and trend combined

    Better than 28% of Nordic stocks

    • Quality61
    • Value60
    • Trend1

    No. 109 of 195 in healthcare

Max for seven days

Follow Induct with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 19 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Induct

From today, at a price of 0.41 NOK. Write why you follow Induct, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Induct

Your first answer is free, no account needed.

Do you own Induct, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Induct and a few more. Free, no card.

Past year against the exchange and Super Stock
Induct−88.8%Oslo Børs (OSEBX)+30.6%Super Stock+46.4%
18 November 202519 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Induct has fallen 88.8% over the past year, including dividends.
  • Overall, Induct ranks better than 28% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 94.3%. The price is 98.9% below its peak now.

What do analysts think of Induct?

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

28

Quality, value and trend together. Better than 28% of Nordic stocks.

No. 109 of 195 in healthcare

Quality61
The company · Fundamentals: the accounts

Medium An average company: the accounts are neither especially strong nor weak.

No. 104 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity0.10
  • Asset turnoverSales divided by everything the company owns0.24
  • Return on equityProfit divided by equity−26.0%
  • Cash conversionOperating cash flow divided by profit–

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value60
The price · Valuation: the multiples

Medium Fair price: about the same as a typical Nordic stock.

No. 29 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50

  • P/BPrice divided by equity0.4
  • P/SPrice divided by sales1.1
  • P/EPrice divided by earningsnegative earnings
  • P/CFPrice divided by operating cash flow–

The ranking is built on P/E, P/B and P/S.

Trend1
The share price · Technical: the price trend

Low Headwind in the share price: it has done worse than most over the last year.

No. 190 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months−50.0%
  • 6 months−80.5%
  • 9 months−90.3%
  • 12 months−88.8%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
−28.2%
3 years, per year
−57.3%
5 years, per year
−45.4%
10 years, per year
−31.0%
Largest fall, 3 years
−94.3%
From a peak to the bottom
From the peak now
−98.9%
How far the price is from the peak
Volatility, 1 year
75.5%
How much the price swings over a year
Beta, 1 year
−0.35
How much the price moves when the market moves

Return with dividends reinvested.

About Induct

Induct AS is a company in healthcare, listed on Oslo Børs. By market value, Induct is number 23 of 23 companies in healthcare on Oslo Børs. Induct has not paid a dividend in the past twelve months. Of the three measures in the ranking, Induct is strongest on quality, better than 61% of Nordic stocks. The share trades in NOK. It has around 13 employees.

Induct AS develops management software in Norway and internationally. The company offers care pathway platform, a disease specific SaS platform; grant platforms; innovation management; and induct.net platform. Induct AS was founded in 2007 and is headquartered in Oslo, Norway.

See the full analysis of Induct.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Oslo Børs

Explore the stock market